Rank | Gene Set | Z-score |
---|---|---|
1 | omega-hydroxylase P450 pathway (GO:0097267) | 7.91867888 |
2 | exogenous drug catabolic process (GO:0042738) | 7.83133948 |
3 | L-phenylalanine catabolic process (GO:0006559) | 7.65122254 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.65122254 |
5 | L-phenylalanine metabolic process (GO:0006558) | 7.33162210 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.33162210 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 6.78864292 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19974671 |
9 | indole-containing compound catabolic process (GO:0042436) | 6.01536821 |
10 | indolalkylamine catabolic process (GO:0046218) | 6.01536821 |
11 | tryptophan catabolic process (GO:0006569) | 6.01536821 |
12 | kynurenine metabolic process (GO:0070189) | 5.95552149 |
13 | bile acid biosynthetic process (GO:0006699) | 5.83378048 |
14 | glyoxylate metabolic process (GO:0046487) | 5.72167451 |
15 | tryptophan metabolic process (GO:0006568) | 5.72056133 |
16 | negative regulation of fibrinolysis (GO:0051918) | 5.61912502 |
17 | urea cycle (GO:0000050) | 5.61026144 |
18 | urea metabolic process (GO:0019627) | 5.61026144 |
19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54418525 |
20 | sulfur amino acid catabolic process (GO:0000098) | 5.49709570 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.47840660 |
22 | ethanol metabolic process (GO:0006067) | 5.44359072 |
23 | regulation of fibrinolysis (GO:0051917) | 5.38241810 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38175222 |
25 | protein carboxylation (GO:0018214) | 5.38175222 |
26 | cysteine metabolic process (GO:0006534) | 5.30167495 |
27 | regulation of protein activation cascade (GO:2000257) | 5.28240180 |
28 | complement activation, alternative pathway (GO:0006957) | 5.24255798 |
29 | oxidative demethylation (GO:0070989) | 5.21515222 |
30 | phenylpropanoid metabolic process (GO:0009698) | 5.20997827 |
31 | serine family amino acid catabolic process (GO:0009071) | 5.20102744 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.13602960 |
33 | bile acid metabolic process (GO:0008206) | 5.04910531 |
34 | negative regulation of protein activation cascade (GO:2000258) | 4.96353721 |
35 | aromatic amino acid family metabolic process (GO:0009072) | 4.94558743 |
36 | regulation of complement activation (GO:0030449) | 4.93214794 |
37 | homocysteine metabolic process (GO:0050667) | 4.87350423 |
38 | tyrosine metabolic process (GO:0006570) | 4.84211111 |
39 | reverse cholesterol transport (GO:0043691) | 4.78619005 |
40 | S-adenosylmethionine metabolic process (GO:0046500) | 4.75204626 |
41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69705372 |
42 | regulation of cholesterol esterification (GO:0010872) | 4.69488689 |
43 | macromolecular complex remodeling (GO:0034367) | 4.66470745 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.66470745 |
45 | protein-lipid complex remodeling (GO:0034368) | 4.66470745 |
46 | alpha-amino acid catabolic process (GO:1901606) | 4.65744235 |
47 | glycine metabolic process (GO:0006544) | 4.63758815 |
48 | triglyceride homeostasis (GO:0070328) | 4.62641474 |
49 | acylglycerol homeostasis (GO:0055090) | 4.62641474 |
50 | lysine metabolic process (GO:0006553) | 4.62636489 |
51 | lysine catabolic process (GO:0006554) | 4.62636489 |
52 | regulation of triglyceride catabolic process (GO:0010896) | 4.61626732 |
53 | coenzyme catabolic process (GO:0009109) | 4.58357942 |
54 | amino-acid betaine metabolic process (GO:0006577) | 4.54526559 |
55 | negative regulation of sterol transport (GO:0032372) | 4.49297424 |
56 | negative regulation of cholesterol transport (GO:0032375) | 4.49297424 |
57 | imidazole-containing compound metabolic process (GO:0052803) | 4.47681426 |
58 | phospholipid efflux (GO:0033700) | 4.43421187 |
59 | bile acid and bile salt transport (GO:0015721) | 4.40577535 |
60 | negative regulation of complement activation (GO:0045916) | 4.39868063 |
61 | plasma lipoprotein particle clearance (GO:0034381) | 4.31885009 |
62 | cellular amino acid catabolic process (GO:0009063) | 4.31214277 |
63 | indolalkylamine metabolic process (GO:0006586) | 4.31119277 |
64 | cellular modified amino acid catabolic process (GO:0042219) | 4.29489115 |
65 | serine family amino acid metabolic process (GO:0009069) | 4.25850546 |
66 | regulation of plasminogen activation (GO:0010755) | 4.25283206 |
67 | cellular ketone body metabolic process (GO:0046950) | 4.17778256 |
68 | cellular glucuronidation (GO:0052695) | 4.17214458 |
69 | glutamate metabolic process (GO:0006536) | 4.14833859 |
70 | cholesterol efflux (GO:0033344) | 4.09963089 |
71 | amine catabolic process (GO:0009310) | 4.09394569 |
72 | cellular biogenic amine catabolic process (GO:0042402) | 4.09394569 |
73 | serine family amino acid biosynthetic process (GO:0009070) | 4.09026090 |
74 | benzene-containing compound metabolic process (GO:0042537) | 3.99302916 |
75 | opsonization (GO:0008228) | 3.94461998 |
76 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.92195447 |
77 | fibrinolysis (GO:0042730) | 3.90682445 |
78 | regulation of humoral immune response (GO:0002920) | 3.89933540 |
79 | plasma lipoprotein particle assembly (GO:0034377) | 3.89114890 |
80 | arginine metabolic process (GO:0006525) | 3.88143536 |
81 | ethanol oxidation (GO:0006069) | 3.86347534 |
82 | aldehyde catabolic process (GO:0046185) | 3.84730378 |
83 | drug catabolic process (GO:0042737) | 3.82870691 |
84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.82562531 |
85 | acute-phase response (GO:0006953) | 3.81999434 |
86 | negative regulation of blood coagulation (GO:0030195) | 3.81973957 |
87 | negative regulation of hemostasis (GO:1900047) | 3.81973957 |
88 | regulation of cholesterol homeostasis (GO:2000188) | 3.80051830 |
89 | cofactor catabolic process (GO:0051187) | 3.79162593 |
90 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77523235 |
91 | heme transport (GO:0015886) | 3.75078880 |
92 | phospholipid homeostasis (GO:0055091) | 3.74822132 |
93 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74002074 |
94 | cholesterol homeostasis (GO:0042632) | 3.72587906 |
95 | carboxylic acid catabolic process (GO:0046395) | 3.72158880 |
96 | organic acid catabolic process (GO:0016054) | 3.72158880 |
97 | xenobiotic catabolic process (GO:0042178) | 3.71995335 |
98 | sterol homeostasis (GO:0055092) | 3.66736023 |
99 | complement activation, classical pathway (GO:0006958) | 3.65732984 |
100 | glucuronate metabolic process (GO:0019585) | 3.65242583 |
101 | uronic acid metabolic process (GO:0006063) | 3.65242583 |
102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62934171 |
103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62934171 |
104 | positive regulation of lipid catabolic process (GO:0050996) | 3.61477760 |
105 | cytolysis (GO:0019835) | 3.61254455 |
106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60838215 |
107 | complement activation (GO:0006956) | 3.60073799 |
108 | protein activation cascade (GO:0072376) | 3.59955471 |
109 | ketone body metabolic process (GO:1902224) | 3.59548808 |
110 | intestinal cholesterol absorption (GO:0030299) | 3.59299077 |
111 | drug metabolic process (GO:0017144) | 3.57191294 |
112 | acetyl-CoA metabolic process (GO:0006084) | 3.57101487 |
113 | negative regulation of lipase activity (GO:0060192) | 3.56369967 |
114 | epoxygenase P450 pathway (GO:0019373) | 3.56099857 |
115 | lipoprotein metabolic process (GO:0042157) | 3.52898601 |
116 | negative regulation of coagulation (GO:0050819) | 3.52183726 |
117 | negative regulation of wound healing (GO:0061045) | 3.50751221 |
118 | plasma lipoprotein particle organization (GO:0071827) | 3.50687868 |
119 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.47467394 |
120 | flavonoid metabolic process (GO:0009812) | 3.43398387 |
121 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.39111887 |
122 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.39111887 |
123 | alkaloid metabolic process (GO:0009820) | 3.36931031 |
124 | negative regulation of humoral immune response (GO:0002921) | 3.32898239 |
125 | primary alcohol metabolic process (GO:0034308) | 3.30490763 |
126 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.28761580 |
127 | xenobiotic metabolic process (GO:0006805) | 3.26535136 |
128 | positive regulation of blood coagulation (GO:0030194) | 3.13904144 |
129 | positive regulation of hemostasis (GO:1900048) | 3.13904144 |
130 | polyketide metabolic process (GO:0030638) | 3.05242525 |
131 | doxorubicin metabolic process (GO:0044598) | 3.05242525 |
132 | daunorubicin metabolic process (GO:0044597) | 3.05242525 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31086985 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19688632 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.76256351 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45110971 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.22288551 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.10009078 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.59933863 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.08805351 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03827689 |
10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.29187899 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.06813417 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06188123 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03011237 |
14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.01848251 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7948468 |
16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97554991 |
17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95124750 |
18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76896449 |
19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.75050996 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71243142 |
21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67719886 |
22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62803381 |
23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57978512 |
24 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.57902120 |
25 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.56104373 |
26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55885129 |
27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.53043921 |
28 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.50321889 |
29 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43937473 |
30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42506062 |
31 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40958728 |
32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.39234004 |
33 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36967537 |
34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36059273 |
35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35878505 |
36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33819907 |
37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.30934816 |
38 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.29194467 |
39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25711598 |
40 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23084106 |
41 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21680569 |
42 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.19021700 |
43 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18559995 |
44 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18016314 |
45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16745858 |
46 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15170065 |
47 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14647460 |
48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13511010 |
49 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.13379217 |
50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13356804 |
51 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13079438 |
52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.12969992 |
53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12933376 |
54 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12112320 |
55 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11327145 |
56 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11027829 |
57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10913701 |
58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10299029 |
59 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.10152036 |
60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09570866 |
61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07136526 |
62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06845947 |
63 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.06655609 |
64 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06587783 |
65 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06492479 |
66 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06492479 |
67 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05320545 |
68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05198840 |
69 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04466431 |
70 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03881846 |
71 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03833442 |
72 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03833442 |
73 | * CBP_21632823_ChIP-Seq_H3396_Human | 1.03596780 |
74 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.03457275 |
75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02608689 |
76 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02580128 |
77 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02358176 |
78 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00612337 |
79 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00042996 |
80 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99856963 |
81 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.99714311 |
82 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.99512937 |
83 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.99434610 |
84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98527743 |
85 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.98360086 |
86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98291863 |
87 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.98285748 |
88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97718429 |
89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97712223 |
90 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97618991 |
91 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97198389 |
92 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.97119220 |
93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97057995 |
94 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96724086 |
95 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96347389 |
96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96347389 |
97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96042600 |
98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94521216 |
99 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.93964552 |
100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93919465 |
101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93151746 |
102 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92751363 |
103 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92493248 |
104 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.91861223 |
105 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.91511039 |
106 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.91511039 |
107 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.91511039 |
108 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.91366007 |
109 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.91210909 |
110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85852318 |
111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85021059 |
112 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.83488992 |
113 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81979586 |
114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80972528 |
115 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78225626 |
116 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77103954 |
117 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76964339 |
118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76591681 |
119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74753618 |
120 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72852351 |
121 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72737336 |
122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72225873 |
123 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70806468 |
124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69578168 |
125 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.69445464 |
126 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69134503 |
127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65586432 |
128 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.64909915 |
129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64565209 |
130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62290845 |
131 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.61723404 |
132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61146234 |
133 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.60851842 |
134 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.60018723 |
135 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.59655679 |
136 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.58994242 |
137 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.57409330 |
138 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.56104912 |
139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.56007795 |
140 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.55098481 |
141 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.54693561 |
142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53200573 |
143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53043449 |
144 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.52372844 |
145 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.51390099 |
146 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.51311539 |
147 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.50561809 |
148 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.50394650 |
149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48475645 |
150 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48284228 |
151 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47851505 |
152 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.47745926 |
153 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.47503691 |
154 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.46279055 |
155 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.45604662 |
156 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.44968907 |
157 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.44804977 |
158 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.42089726 |
159 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.41206057 |
160 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.40660632 |
161 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.40660632 |
162 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.39702794 |
163 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.38994595 |
164 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.38770352 |
165 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38394510 |
166 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.38360861 |
167 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.37787904 |
168 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37601250 |
169 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.37514726 |
170 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.36948803 |
171 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.36850974 |
172 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.36489366 |
173 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.36479888 |
174 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.35732249 |
175 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35189730 |
176 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.35131017 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.17649251 |
2 | MP0005360_urolithiasis | 7.25710287 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.41693763 |
4 | MP0005365_abnormal_bile_salt | 6.17505176 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.96392961 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.54168343 |
7 | MP0003252_abnormal_bile_duct | 4.00963924 |
8 | MP0010329_abnormal_lipoprotein_level | 3.45725138 |
9 | MP0009840_abnormal_foam_cell | 3.16193327 |
10 | MP0003195_calcinosis | 3.08206009 |
11 | MP0005083_abnormal_biliary_tract | 3.05182076 |
12 | MP0005332_abnormal_amino_acid | 2.66059526 |
13 | MP0001666_abnormal_nutrient_absorption | 2.53588051 |
14 | MP0009780_abnormal_chondrocyte_physiolo | 2.41691136 |
15 | MP0005379_endocrine/exocrine_gland_phen | 2.20959762 |
16 | MP0000609_abnormal_liver_physiology | 2.17203569 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.04066122 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.01129916 |
19 | MP0003868_abnormal_feces_composition | 1.97638968 |
20 | MP0003191_abnormal_cellular_cholesterol | 1.96916380 |
21 | MP0002138_abnormal_hepatobiliary_system | 1.89407177 |
22 | MP0002909_abnormal_adrenal_gland | 1.86266657 |
23 | MP0005319_abnormal_enzyme/_coenzyme | 1.82381062 |
24 | MP0000013_abnormal_adipose_tissue | 1.67334823 |
25 | MP0003705_abnormal_hypodermis_morpholog | 1.66800892 |
26 | MP0009697_abnormal_copulation | 1.59597324 |
27 | MP0001764_abnormal_homeostasis | 1.53712999 |
28 | MP0003011_delayed_dark_adaptation | 1.47592783 |
29 | MP0005645_abnormal_hypothalamus_physiol | 1.39026905 |
30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37184368 |
31 | MP0009643_abnormal_urine_homeostasis | 1.26593281 |
32 | MP0002254_reproductive_system_inflammat | 1.25988618 |
33 | MP0000598_abnormal_liver_morphology | 1.25072575 |
34 | MP0003186_abnormal_redox_activity | 1.23760008 |
35 | MP0005451_abnormal_body_composition | 1.21171046 |
36 | MP0005646_abnormal_pituitary_gland | 1.07767093 |
37 | MP0002163_abnormal_gland_morphology | 1.05182407 |
38 | MP0004264_abnormal_extraembryonic_tissu | 1.04795755 |
39 | MP0010368_abnormal_lymphatic_system | 1.02906417 |
40 | MP0003879_abnormal_hair_cell | 0.98999694 |
41 | MP0005647_abnormal_sex_gland | 0.95029082 |
42 | MP0003656_abnormal_erythrocyte_physiolo | 0.94967761 |
43 | MP0002078_abnormal_glucose_homeostasis | 0.93956297 |
44 | MP0005220_abnormal_exocrine_pancreas | 0.93084951 |
45 | MP0009763_increased_sensitivity_to | 0.92226256 |
46 | MP0005670_abnormal_white_adipose | 0.90076788 |
47 | MP0010386_abnormal_urinary_bladder | 0.89511265 |
48 | MP0008872_abnormal_physiological_respon | 0.86732799 |
49 | MP0009053_abnormal_anal_canal | 0.86521299 |
50 | MP0006036_abnormal_mitochondrial_physio | 0.86338349 |
51 | MP0005408_hypopigmentation | 0.85978875 |
52 | MP0005636_abnormal_mineral_homeostasis | 0.83785673 |
53 | MP0009642_abnormal_blood_homeostasis | 0.82131144 |
54 | MP0005266_abnormal_metabolism | 0.81475553 |
55 | MP0005376_homeostasis/metabolism_phenot | 0.80713418 |
56 | MP0003122_maternal_imprinting | 0.80314478 |
57 | MP0000003_abnormal_adipose_tissue | 0.79423261 |
58 | MP0006072_abnormal_retinal_apoptosis | 0.72998915 |
59 | MP0000604_amyloidosis | 0.72460459 |
60 | MP0009764_decreased_sensitivity_to | 0.72144325 |
61 | MP0005551_abnormal_eye_electrophysiolog | 0.71930015 |
62 | MP0001661_extended_life_span | 0.71662376 |
63 | MP0008469_abnormal_protein_level | 0.70152838 |
64 | MP0000639_abnormal_adrenal_gland | 0.69870945 |
65 | MP0009765_abnormal_xenobiotic_induced | 0.68031844 |
66 | MP0006035_abnormal_mitochondrial_morpho | 0.66971509 |
67 | MP0009672_abnormal_birth_weight | 0.65097169 |
68 | MP0002971_abnormal_brown_adipose | 0.64700284 |
69 | MP0005334_abnormal_fat_pad | 0.64597904 |
70 | MP0005248_abnormal_Harderian_gland | 0.64476351 |
71 | MP0001756_abnormal_urination | 0.64071978 |
72 | MP0002295_abnormal_pulmonary_circulatio | 0.63950461 |
73 | MP0003283_abnormal_digestive_organ | 0.63242827 |
74 | MP0002837_dystrophic_cardiac_calcinosis | 0.62612095 |
75 | MP0005084_abnormal_gallbladder_morpholo | 0.62225175 |
76 | MP0002876_abnormal_thyroid_physiology | 0.56633605 |
77 | MP0003787_abnormal_imprinting | 0.55210084 |
78 | MP0005448_abnormal_energy_balance | 0.54567058 |
79 | MP0003633_abnormal_nervous_system | 0.54201196 |
80 | MP0004130_abnormal_muscle_cell | 0.54076953 |
81 | MP0002928_abnormal_bile_duct | 0.52772711 |
82 | MP0005535_abnormal_body_temperature | 0.52435645 |
83 | MP0002938_white_spotting | 0.52335137 |
84 | MP0002090_abnormal_vision | 0.51116493 |
85 | MP0005395_other_phenotype | 0.50742064 |
86 | MP0001944_abnormal_pancreas_morphology | 0.50220875 |
87 | MP0003890_abnormal_embryonic-extraembry | 0.48424127 |
88 | MP0004043_abnormal_pH_regulation | 0.47863789 |
89 | MP0003718_maternal_effect | 0.47471198 |
90 | MP0002132_abnormal_respiratory_system | 0.47061043 |
91 | MP0001984_abnormal_olfaction | 0.45681260 |
92 | MP0005058_abnormal_lysosome_morphology | 0.45398416 |
93 | MP0003172_abnormal_lysosome_physiology | 0.44932897 |
94 | MP0003953_abnormal_hormone_level | 0.44631952 |
95 | MP0000372_irregular_coat_pigmentation | 0.44089769 |
96 | MP0005452_abnormal_adipose_tissue | 0.42261157 |
97 | MP0005666_abnormal_adipose_tissue | 0.41699181 |
98 | MP0002269_muscular_atrophy | 0.41074293 |
99 | MP0002970_abnormal_white_adipose | 0.40846805 |
100 | MP0004782_abnormal_surfactant_physiolog | 0.40794197 |
101 | MP0001765_abnormal_ion_homeostasis | 0.40016334 |
102 | MP0004142_abnormal_muscle_tone | 0.39656143 |
103 | MP0001243_abnormal_dermal_layer | 0.39573284 |
104 | MP0004270_analgesia | 0.39327755 |
105 | MP0008877_abnormal_DNA_methylation | 0.38381372 |
106 | MP0008873_increased_physiological_sensi | 0.37959975 |
107 | MP0002136_abnormal_kidney_physiology | 0.37521923 |
108 | MP0003638_abnormal_response/metabolism_ | 0.35932740 |
109 | MP0001986_abnormal_taste_sensitivity | 0.35611452 |
110 | MP0009046_muscle_twitch | 0.35054099 |
111 | MP0002069_abnormal_eating/drinking_beha | 0.34469960 |
112 | MP0005187_abnormal_penis_morphology | 0.33966490 |
113 | MP0002168_other_aberrant_phenotype | 0.33811773 |
114 | MP0010234_abnormal_vibrissa_follicle | 0.33376850 |
115 | MP0002796_impaired_skin_barrier | 0.33321534 |
116 | MP0005023_abnormal_wound_healing | 0.32802098 |
117 | MP0003690_abnormal_glial_cell | 0.32505200 |
118 | MP0002693_abnormal_pancreas_physiology | 0.29093307 |
119 | MP0009115_abnormal_fat_cell | 0.28201228 |
120 | MP0000579_abnormal_nail_morphology | 0.27758209 |
121 | MP0000230_abnormal_systemic_arterial | 0.27707282 |
122 | MP0009384_cardiac_valve_regurgitation | 0.27590788 |
123 | MP0003329_amyloid_beta_deposits | 0.27108237 |
124 | MP0002060_abnormal_skin_morphology | 0.25527164 |
125 | MP0000249_abnormal_blood_vessel | 0.24786644 |
126 | MP0001915_intracranial_hemorrhage | 0.22739735 |
127 | MP0004883_abnormal_blood_vessel | 0.22679851 |
128 | MP0000427_abnormal_hair_cycle | 0.22406475 |
129 | MP0002135_abnormal_kidney_morphology | 0.21690467 |
130 | MP0001881_abnormal_mammary_gland | 0.21430505 |
131 | MP0008874_decreased_physiological_sensi | 0.21235051 |
132 | MP0003119_abnormal_digestive_system | 0.21095216 |
133 | MP0009703_decreased_birth_body | 0.19553271 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.49984986 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.48790042 |
3 | Deep venous thrombosis (HP:0002625) | 7.22222116 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.82774609 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.42153482 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.34977314 |
7 | Xanthomatosis (HP:0000991) | 6.23360589 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.24231181 |
9 | Complement deficiency (HP:0004431) | 5.10744516 |
10 | Hypolipoproteinemia (HP:0010981) | 4.83425716 |
11 | Hypoglycemic coma (HP:0001325) | 4.55987843 |
12 | Epidermoid cyst (HP:0200040) | 4.52332452 |
13 | Hyperammonemia (HP:0001987) | 4.52001127 |
14 | Joint hemorrhage (HP:0005261) | 4.49802919 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.49723918 |
16 | Hyperglycinemia (HP:0002154) | 4.39022366 |
17 | Ketosis (HP:0001946) | 4.35741184 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.35451208 |
19 | Abnormality of methionine metabolism (HP:0010901) | 4.28954223 |
20 | Abnormality of the intrinsic pathway (HP:0010989) | 4.28938406 |
21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26278905 |
22 | Hypoalphalipoproteinemia (HP:0003233) | 4.22786311 |
23 | Fat malabsorption (HP:0002630) | 4.11042527 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.03554942 |
25 | Hyperglycinuria (HP:0003108) | 3.97156013 |
26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.97096969 |
27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.87344030 |
28 | Abnormality of glycine metabolism (HP:0010895) | 3.86968577 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86968577 |
30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.82912104 |
31 | Abnormality of complement system (HP:0005339) | 3.73227099 |
32 | Hypochromic microcytic anemia (HP:0004840) | 3.58366294 |
33 | Hypercholesterolemia (HP:0003124) | 3.55069411 |
34 | Ketoacidosis (HP:0001993) | 3.36706710 |
35 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.32784759 |
36 | Hyperbilirubinemia (HP:0002904) | 3.31568494 |
37 | Hypoglycemic seizures (HP:0002173) | 3.29771008 |
38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22996938 |
39 | Abnormality of vitamin metabolism (HP:0100508) | 3.20247262 |
40 | Skin nodule (HP:0200036) | 3.15999346 |
41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.10782206 |
42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08154097 |
43 | Hepatocellular carcinoma (HP:0001402) | 3.07985801 |
44 | Delayed CNS myelination (HP:0002188) | 2.99767603 |
45 | Nephritis (HP:0000123) | 2.98861188 |
46 | Steatorrhea (HP:0002570) | 2.96114625 |
47 | Abnormality of serum amino acid levels (HP:0003112) | 2.95531665 |
48 | Hypothermia (HP:0002045) | 2.86685180 |
49 | Abnormality of urine glucose concentration (HP:0011016) | 2.81094618 |
50 | Glycosuria (HP:0003076) | 2.81094618 |
51 | Myocardial infarction (HP:0001658) | 2.71544055 |
52 | Abnormality of purine metabolism (HP:0004352) | 2.68559131 |
53 | Metabolic acidosis (HP:0001942) | 2.67132355 |
54 | Spontaneous abortion (HP:0005268) | 2.66466670 |
55 | Gout (HP:0001997) | 2.60310563 |
56 | Spastic diplegia (HP:0001264) | 2.55392043 |
57 | Fair hair (HP:0002286) | 2.52960595 |
58 | Dicarboxylic aciduria (HP:0003215) | 2.51604497 |
59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51604497 |
60 | Lethargy (HP:0001254) | 2.50270857 |
61 | Irritability (HP:0000737) | 2.50202086 |
62 | Proximal tubulopathy (HP:0000114) | 2.48804316 |
63 | Abnormal gallbladder morphology (HP:0012437) | 2.47193459 |
64 | Hyperglycemia (HP:0003074) | 2.46668553 |
65 | Late onset (HP:0003584) | 2.44618395 |
66 | Enlarged kidneys (HP:0000105) | 2.38514393 |
67 | Malnutrition (HP:0004395) | 2.38423998 |
68 | Acanthocytosis (HP:0001927) | 2.36214876 |
69 | Cholelithiasis (HP:0001081) | 2.32390395 |
70 | Systemic lupus erythematosus (HP:0002725) | 2.31517304 |
71 | Osteomalacia (HP:0002749) | 2.31253333 |
72 | Symptomatic seizures (HP:0011145) | 2.30931537 |
73 | Vascular calcification (HP:0004934) | 2.30791722 |
74 | Arthropathy (HP:0003040) | 2.28401313 |
75 | Abnormal cartilage morphology (HP:0002763) | 2.27227745 |
76 | Esophageal varix (HP:0002040) | 2.26207474 |
77 | Hyperphosphaturia (HP:0003109) | 2.24770698 |
78 | Cerebral edema (HP:0002181) | 2.21180047 |
79 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.19574302 |
80 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.19574302 |
81 | Mitral stenosis (HP:0001718) | 2.19463259 |
82 | Neonatal onset (HP:0003623) | 2.18201495 |
83 | Neonatal hypoglycemia (HP:0001998) | 2.17076885 |
84 | Abnormal gallbladder physiology (HP:0012438) | 2.16290426 |
85 | Cholecystitis (HP:0001082) | 2.16290426 |
86 | Generalized aminoaciduria (HP:0002909) | 2.15850405 |
87 | Glomerulonephritis (HP:0000099) | 2.15296531 |
88 | Abnormality of vitamin B metabolism (HP:0004340) | 2.14196584 |
89 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.13889933 |
90 | Pancreatitis (HP:0001733) | 2.04715943 |
91 | Increased CSF protein (HP:0002922) | 2.04165276 |
92 | Cardiovascular calcification (HP:0011915) | 2.03678209 |
93 | Brushfield spots (HP:0001088) | 2.03614621 |
94 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00341696 |
95 | Rickets (HP:0002748) | 1.98475259 |
96 | Abnormality of the gallbladder (HP:0005264) | 1.96024914 |
97 | Large for gestational age (HP:0001520) | 1.95235913 |
98 | Hepatoblastoma (HP:0002884) | 1.95040708 |
99 | Menorrhagia (HP:0000132) | 1.94927502 |
100 | Vomiting (HP:0002013) | 1.94161425 |
101 | Amyloidosis (HP:0011034) | 1.91090079 |
102 | Sensorimotor neuropathy (HP:0007141) | 1.90295680 |
103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88684648 |
104 | Gingival bleeding (HP:0000225) | 1.88472515 |
105 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86014618 |
106 | Thrombophlebitis (HP:0004418) | 1.85871002 |
107 | Methylmalonic acidemia (HP:0002912) | 1.85822294 |
108 | Generalized hypopigmentation of hair (HP:0011358) | 1.84643473 |
109 | Abnormality of iron homeostasis (HP:0011031) | 1.82887073 |
110 | Hypophosphatemic rickets (HP:0004912) | 1.82559525 |
111 | Blue irides (HP:0000635) | 1.82169341 |
112 | Intestinal atresia (HP:0011100) | 1.81622362 |
113 | Opisthotonus (HP:0002179) | 1.81124232 |
114 | Hydroxyprolinuria (HP:0003080) | 1.79975823 |
115 | Abnormality of proline metabolism (HP:0010907) | 1.79975823 |
116 | Elevated alkaline phosphatase (HP:0003155) | 1.79005238 |
117 | Poikilocytosis (HP:0004447) | 1.78082435 |
118 | Hemorrhage of the eye (HP:0011885) | 1.77866193 |
119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77354677 |
120 | Reticulocytosis (HP:0001923) | 1.75259407 |
121 | Renal cortical cysts (HP:0000803) | 1.74668155 |
122 | Abnormal urine phosphate concentration (HP:0012599) | 1.69857448 |
123 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.67803158 |
124 | Abnormal biliary tract physiology (HP:0012439) | 1.65090588 |
125 | Bile duct proliferation (HP:0001408) | 1.65090588 |
126 | Congenital malformation of the right heart (HP:0011723) | 1.63619209 |
127 | Double outlet right ventricle (HP:0001719) | 1.63619209 |
128 | Mucopolysacchariduria (HP:0008155) | 1.63102345 |
129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.63102345 |
130 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.62826741 |
131 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.62826741 |
132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.62826741 |
133 | Joint swelling (HP:0001386) | 1.56017950 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.29885976 |
2 | ERN1 | 4.73933680 |
3 | SIK1 | 4.02580646 |
4 | FGFR4 | 3.86348102 |
5 | INSRR | 3.72762262 |
6 | TAOK3 | 3.07739160 |
7 | PHKG2 | 2.81469957 |
8 | PHKG1 | 2.81469957 |
9 | FLT3 | 2.69696062 |
10 | ERBB4 | 2.62433879 |
11 | PKN2 | 2.58693539 |
12 | LATS1 | 2.32125805 |
13 | NTRK3 | 2.14624631 |
14 | MST4 | 2.14289715 |
15 | CDK12 | 2.03617349 |
16 | MAP2K4 | 1.98368755 |
17 | MAP4K2 | 1.91327183 |
18 | TRPM7 | 1.88428176 |
19 | NLK | 1.84624935 |
20 | TRIB3 | 1.84324467 |
21 | PIK3CG | 1.69792318 |
22 | ADRBK2 | 1.64119835 |
23 | STK16 | 1.61911742 |
24 | PTK6 | 1.59208182 |
25 | MAP3K10 | 1.55138003 |
26 | FRK | 1.55126373 |
27 | MAPK11 | 1.54098880 |
28 | STK38L | 1.52448345 |
29 | MST1R | 1.49372545 |
30 | MET | 1.48548163 |
31 | PRKCE | 1.48163896 |
32 | EPHA2 | 1.36969701 |
33 | MAP3K4 | 1.35372805 |
34 | TNK2 | 1.30810316 |
35 | MAPK15 | 1.27655855 |
36 | CAMK2D | 1.26539308 |
37 | GRK6 | 1.21351125 |
38 | UHMK1 | 1.21058156 |
39 | MAP3K12 | 1.18131864 |
40 | KDR | 1.16030077 |
41 | MAP3K3 | 1.13693578 |
42 | AKT3 | 1.12458245 |
43 | WNK4 | 1.09099589 |
44 | NEK9 | 1.06725272 |
45 | ABL2 | 1.05339101 |
46 | PTK2 | 1.04316738 |
47 | ERBB2 | 1.02200250 |
48 | MYLK | 1.01569980 |
49 | TYK2 | 0.96922339 |
50 | JAK2 | 0.96885067 |
51 | MAP3K7 | 0.95685065 |
52 | MAP3K9 | 0.94172432 |
53 | FGFR2 | 0.93523879 |
54 | PRKAA2 | 0.93261379 |
55 | MAP2K3 | 0.93093676 |
56 | YES1 | 0.92135401 |
57 | BMPR1B | 0.90542314 |
58 | PDGFRA | 0.88362201 |
59 | MTOR | 0.86355782 |
60 | MAPK7 | 0.85908336 |
61 | PASK | 0.84438416 |
62 | EIF2AK3 | 0.83744018 |
63 | CAMKK2 | 0.82062973 |
64 | ERBB3 | 0.81424675 |
65 | EPHA3 | 0.80174313 |
66 | NEK1 | 0.79263100 |
67 | CDK6 | 0.79204068 |
68 | MUSK | 0.79056163 |
69 | PRKG1 | 0.76127884 |
70 | PIK3CA | 0.75581672 |
71 | STK4 | 0.75469992 |
72 | HIPK2 | 0.74217294 |
73 | GSK3A | 0.72938743 |
74 | PRKAA1 | 0.72872224 |
75 | TGFBR2 | 0.71135506 |
76 | FGFR3 | 0.71012258 |
77 | CSNK1G3 | 0.70744039 |
78 | DYRK1B | 0.69866135 |
79 | LATS2 | 0.68443729 |
80 | RIPK1 | 0.68318407 |
81 | PRKACG | 0.67843554 |
82 | GRK1 | 0.67122016 |
83 | PRKD3 | 0.67108173 |
84 | PRKACA | 0.65868739 |
85 | TTK | 0.64217465 |
86 | DAPK2 | 0.63163168 |
87 | CSF1R | 0.62333895 |
88 | PTK2B | 0.60385568 |
89 | CSNK1G2 | 0.57966293 |
90 | CSK | 0.57843378 |
91 | CDK4 | 0.57413354 |
92 | CASK | 0.56995242 |
93 | PLK2 | 0.55303596 |
94 | CSNK1D | 0.55209154 |
95 | PRKCZ | 0.54874044 |
96 | CAMK1D | 0.54711132 |
97 | STK39 | 0.54313283 |
98 | PINK1 | 0.53826245 |
99 | MAP2K7 | 0.53172255 |
100 | PRKACB | 0.52939954 |
101 | MAPK4 | 0.52447542 |
102 | MKNK2 | 0.52377652 |
103 | CSNK1A1 | 0.51439660 |
104 | TIE1 | 0.51092504 |
105 | IGF1R | 0.50644243 |
106 | IRAK1 | 0.49959444 |
107 | OXSR1 | 0.49864455 |
108 | MAP2K6 | 0.49779364 |
109 | STK3 | 0.49754159 |
110 | JAK1 | 0.49116614 |
111 | MAP3K2 | 0.48443939 |
112 | STK11 | 0.47806358 |
113 | TNIK | 0.47773337 |
114 | PRKCA | 0.47716394 |
115 | PRKCI | 0.47499311 |
116 | PAK3 | 0.45841646 |
117 | CAMK1G | 0.45792481 |
118 | LIMK1 | 0.43946847 |
119 | MAPK12 | 0.40967998 |
120 | CAMK4 | 0.40101540 |
121 | PRKD2 | 0.40056267 |
122 | ICK | 0.38907233 |
123 | RET | 0.38773701 |
124 | STK38 | 0.38001997 |
125 | SGK2 | 0.37995696 |
126 | ACVR1B | 0.37276415 |
127 | STK24 | 0.37251726 |
128 | MAP3K11 | 0.37201596 |
129 | FGFR1 | 0.36854494 |
130 | SGK1 | 0.36205269 |
131 | ADRBK1 | 0.36060124 |
132 | MAP2K2 | 0.35647615 |
133 | PRKCB | 0.35433782 |
134 | ZAK | 0.35324501 |
135 | CAMK2G | 0.35189182 |
136 | MAPK13 | 0.35076678 |
137 | MAP3K5 | 0.34931377 |
138 | MAP2K1 | 0.34928885 |
139 | FER | 0.34576187 |
140 | GRK5 | 0.34304823 |
141 | IRAK3 | 0.33761183 |
142 | EPHB1 | 0.33619268 |
143 | MAP3K1 | 0.33277303 |
144 | OBSCN | 0.31665614 |
145 | PRKG2 | 0.30384813 |
146 | TAOK2 | 0.30330058 |
147 | SGK3 | 0.29913963 |
148 | CSNK1E | 0.29093065 |
149 | EGFR | 0.29038129 |
150 | NTRK1 | 0.29009226 |
151 | AKT2 | 0.27052505 |
152 | TBK1 | 0.26783185 |
153 | CSNK1G1 | 0.24782558 |
154 | WNK3 | 0.21604370 |
155 | MAP3K8 | 0.21155164 |
156 | PRKCG | 0.18917474 |
157 | MAPK1 | 0.18345049 |
158 | BRSK2 | 0.18253805 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41218956 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64125258 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.41229521 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33347730 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02250114 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.77156672 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70675487 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61112728 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57175024 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53374731 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43221546 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41182643 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26858295 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09327385 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04666141 |
16 | Peroxisome_Homo sapiens_hsa04146 | 1.98321693 |
17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91497532 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89352457 |
19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.85735460 |
20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.85653405 |
21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84929628 |
22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84625317 |
23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.83166392 |
24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83047649 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77832338 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72684655 |
27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.70763796 |
28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66693589 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65506374 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64411432 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62159766 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59725490 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56165297 |
34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55804258 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54316829 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.45877385 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45186187 |
38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44803903 |
39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35543075 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34042427 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33988873 |
42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33882103 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31885053 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29108964 |
45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23067312 |
46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21258879 |
47 | ABC transporters_Homo sapiens_hsa02010 | 1.21101240 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18388616 |
49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09630066 |
50 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07719843 |
51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04363228 |
52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97263443 |
53 | Lysine degradation_Homo sapiens_hsa00310 | 0.91924616 |
54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89277312 |
55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89259934 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84808555 |
57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81306174 |
58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79588720 |
59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79050313 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72304465 |
61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69801692 |
62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64646732 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64112678 |
64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60625400 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59042200 |
66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50117246 |
67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48832818 |
68 | Insulin secretion_Homo sapiens_hsa04911 | 0.48761018 |
69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46503993 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42773722 |
71 | Prion diseases_Homo sapiens_hsa05020 | 0.39522176 |
72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38390429 |
73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37257465 |
74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35710253 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34827847 |
76 | Insulin resistance_Homo sapiens_hsa04931 | 0.33503283 |
77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28694094 |
78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26482428 |
79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25762530 |
80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21361473 |
81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20698218 |
82 | Mineral absorption_Homo sapiens_hsa04978 | 0.20566514 |
83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20065097 |
84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17743554 |
85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.17646537 |
86 | Pertussis_Homo sapiens_hsa05133 | 0.16753124 |
87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16720193 |
88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.15936949 |
89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14311327 |
90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13078479 |
91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10592829 |
92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09708626 |
93 | Renin secretion_Homo sapiens_hsa04924 | 0.00519660 |
94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1838874 |
95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1810434 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1810160 |
97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1707256 |
98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1641219 |
99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1612742 |
100 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1612001 |
101 | Bladder cancer_Homo sapiens_hsa05219 | -0.1495213 |
102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1367031 |
103 | Protein export_Homo sapiens_hsa03060 | -0.0953231 |
104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0888167 |
105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0849608 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0802275 |
107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0637070 |
108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0598870 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0547301 |
110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0545138 |
111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0501260 |
112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0491173 |
113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.0361873 |
114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0190544 |